News

Project 8p Research Newsletter – November 2023

The most recent Segment to be added to the Project 8p Research Plan is the Fifth Segment focused on Augmentative Devices and Assistive Technologies. At the October Research Roundtable we talked with 8p families about their successes and struggles with various assistive technologies that they use or have tried with their 8p heroes.

Neuroaugmentative technologies are a particularly exciting and active area of research in this field. In the near future, such technologies have the potential to help control seizures, and improve speech and motor function. Project 8p is actively seeking out companies and researchers developing these technologies in order to bring their devices to 8p heroes. At the October Roundtable, we were joined by ActiPulse Neuroscience CEO Adrien Châtillon and CSO Gabriel Villafuerte, who shared their non-invasive brain technology that is being developed to treat Major Depressive Disorder, enhance drug delivery to the brain, and treat brain cancers, all by applying magnetic pulses to the brain. 

CONTINUE READING

The Project 8p Foundation (Project 8p) was created in 2018 to:

  • Accelerate future treatments, not only for 8p, but potentially for other chromosome-wide diseases as well.
  • Lead with knowledge from patients. Currently, there is no cure for 8p disorders, nor is there a standard course of treatment.

The Project 8p Foundation (Project 8p) was created in 2018 to:

  • Raise transformative funding for pioneering scientific research into treatments for a complex, rare disease involving 250+ affected genes on the short arm of the 8 th chromosome (8p). Rearrangements of these genes causes significant abnormalities to the entire neurological system, thus all organs and functions of the body– with variance in cognitive functions, gross motor skills, social development and other challenges during infancy, and throughout life;
  • Empower a unified community of 8p patients and their families so they can have meaningful lives today; and
  • Accelerate future treatments, not only for 8p, but potentially for other chromosome-wide diseases as well.